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INTRODUCTION 
Nature has given on us a very rich botanical wealth and various types of plants grow 
in different parts of the country (Jignaet al., 2005). According to a conservative estimation, 
300,000-400,000 plant species grow on Earth; however, only a small percentage have had 
their phytochemistry and biological function investigated (Kitani,  et al., 2001). Since ancient 
times herbal medicine are used for various treatment and in most of the developing countries 
75-80% of the whole population rely on herbal medicine because of better cultural 
acceptability, better compatibility with the human body and fewer side effects. Hence, the last 
few years have seen a major increase in their use in the developed countries. For example 
four out of ten Americans used alternative medicine therapies in 1997; total visits to 
alternative medicine practitioners increased by almost 50% from 1990 and exceeded the visits 
to all US primary care physicians (Grabley and Thiericke, 1999). Thirty per cent of the 
worldwide sales of drugs are based on natural products. India is rich in different levels of 
biodiversity, namely species diversity, genetic diversity and habitat diversity. In India 
enormous number of medicinal plants are available naturally which accounts for great 
economic values (Jignaet al., 2005). 
The Indian system of medicine (Ayurveda, Siddha) and Chinese system of medicine 
are two of the most extensively developed medicinal system in the world.  Since ancient 
times Ayurveda remains one of the most and yet living traditions practised widely in India, 
Sri Lanka and other countries and has a sound philosophical and experiential basis 
(Dahanukaret al., 2000; Chopra and Doiphode, 2002). Indian healthcare consists of medical 
pluralism and Ayurveda still remains dominant compared to allopathic medicine, especially 
for treatment of a variety of chronic disease conditions (Waxler, 1998). Total global herbal 
drug market including herbal products and raw material is estimated as US $62 billion with 
the annual growth rate of 5-15% and is expected to grow US $5 trillion by the year 2050. 
Ayurveda contributes Rs 3500 crores (US $813 million) annually to the internal market. The 
Indian medicinal plants-based industry is growing at the rate of 7–15% annually. The value 
of medicinal plants-related trade in India is estimated at Rs 5000 crores per annum. Global 
trend leading to increased demand of medicinal plants for pharmaceuticals, phytochemicals, 
nutraceuticals, cosmetics and other products is an opportunity sector for Indian trade and 
commerce (Singh et al., 2003). Herbal preparations and phytomedicines are increasingly 
being used by the public as self-selected OTC products for therapeutic or preventative 
purposes. Hence, pharmaceutical sector is focused on development of new drugs, 
innovative/indigenous processes for known drugs and development of plant-based drugs 
through investigation of leads from the traditional systems of medicine. Even though the 
current accepted modern medicine or Allopathy has gradually developed over the years by 
scientific and observational efforts of scientists, the basis of its development remains rooted 
in traditional medicine and therapies.  Ancient wisdom has been the basis of modern 
medicine and will remain as one important source of future medicine and therapeutics 
(Patwardhan and Hooper, 1992).  
Nature based treatments gaining much importance now a days due to number of 
reasons like development of drug-resistance by microorganisms to antibiotics, side effects of 
modern drugs, and emerging diseases where no medicines are available, which have 
stimulated the interest on plants as a significant source of new medicines. Researchers are 
experiencing difficulty in identifying new lead structures, templates and scaffolds in the finite 
world of chemical diversity. A number of synthetic drugs have adverse and unacceptable side 
effects. There have been impressive successes with botanical medicines. Considerable 
research on pharmacognosy, chemistry, pharmacology and clinical therapeutics has been 
carried out on (Dahanukaret al., 2000) to bring the numerous molecules like  rauwolfia 
alkaloids for hypertension, psoralens in vitiligo, holarrhena alkaloids in amoebiasis, 
guggulsterons as hypolipidemic agents, mucunapruriensfor Parkinson’s disease, piperidines 
as bioavailability enhancers and baccosides in mental retention (Patwardhan, 2003). A whole 
range of chronic and difficult-to-treat diseases such as cancers, cardiovascular disease, 
diabetes, rheumatism and AIDS, all require new effective drugs. Therefore, pharmaceutical 
industry is now focused to develop herbal based medicines. As a result many herbal products 
are available in market but the quality, efficacy and safety remain unclear. Because herbal 
products are easily adulterated, mislabelled and even lacking in active content. Hence, 
standardization is an important issue and this seems to be a logical solution for quality control 
of herbal products, however it is not an easy process due to the presence of complex 
phytoconstituents.  
Most of the standard setting organisations like Indian Pharmacopoeia, European 
Pharmacopoeia and British Pharmacopoeia contain important requirements pertaining to 
certain analytical procedures and acceptance criteria that are relevant to herbal drugs, herbal 
preparations and their formulations for quality control and standardization. Validated 
analytical procedures are required for the quantification of active compounds present in 
herbal medicinal preparations. For these, chromatographic methods like high performance 
liquid chromatography (HPLC), thin layer chromatography (TLC), high performance thin 
layer chromatography (HPTLC), and gas chromatography (GC) are routinely used as 
valuable tools for qualitative determination of small amounts of impurities, Identification and 
quantification of active constituent present in the herbal formulations. (Quality Control 
Methods for Medicinal Plant Materials, WHO, Geneva, 1998). 
 High-performance liquid chromatography (HPLC) is nowadays one of the separation 
techniques most extensively used in the phytochemistry and pharmaceutical industry for 
quality control because of its high selectivity, efficacy and speed (Merken and Beecher, 
2000). Validation of an HPLC test method is mandatory in implementing a quality control 
system in any laboratory and ensures that the methodology is sufficiently selective, accurate, 
reproducible and robust over the range specified for analysis (ICH, 1996) 
 The present study is aimed to develop a validated HPLC method for the quantification 
of All-trans retinoic acid in plant extracts namely  Broccoli (Brassica oleracea), Spinach 
(Spinacia oleracea).                                                                                                                  
      Analytical methods development and validation [1-4] plays a crucial role in the 
discovery, development, and manufacture of pharmaceuticals. 
                Pharmaceutical products formulated with more than one drug, typically referred to 
as combination products, are intended to meet previously unmet patients need by combining 
the therapeutic effects of two or more drugs in one product.  
                These combination products can present daunting challenges to the analytical 
chemist responsible for the development and validation of analytical methods. High 
performance liquid chromatography (HPLC) for drug products containing more than one 
active ingredient. The official test methods that result from these processes are used by 
quality control laboratories to ensure the identity, purity, potency, and performance of drug 
products.  
              The drugs may be either new entities or partial structural modification of the existing 
one. Very often there is a time lag from the date of introduction of a drug into the market to 
the date of its inclusion in pharmacopoeias. This happens because of the possible 
uncertainties in the continuous and wider usage of these drugs, reports of new toxicities 
(resulting in their withdrawal from the market), development of patient resistance and 
introduction of better drugs by competitors. Under these conditions, standards and analytical 
procedures for these drugs may not be available in the pharmacopoeias. It becomes 
necessary, therefore to develop newer analytical methods for such drugs.  
            Importance of analytical chemistry is to gain information about the qualitative and 
quantitative composition of substance and chemical species, that is, to find out what a 
substance is composed of and exactly how much it is present. 
Pharmaceutical analysis deals with the analysis of the pharmaceutical substances. It is 
generally known that pharmaceutical is a chemical entity of therapeutic interest. 
           Pharmaceutical analysts in research and development (R&D) of pharma industry plays 
a vital role in new drug development and follow up activities to assure that, a new drug 
product meets the established standards, its stability, and continued to meet the purported 
quality throughout its shelf life. 
Analytical method development is required for: 
¾ Herbal products 
¾ New process and reactions 
¾ Active ingredients (Macro analysis) 
¾ Residues (Microanalysis) 
¾ Impurity profiling  
¾ Component of interest in different matrices 
¾ Clinical pharmacokinetic studies 
¾ Quality control department in industries 
Basic criteria for new method development of drug analysis:  
 The drug or drug combination may not be official in any pharmacopoeias,  
 A proper analytical procedure for the drug may not be available in the literature due to 
patent regulations,  
 Analytical methods may not be available for the drug in the form of a formulation due 
to the interference caused by the formulation excipients,  
 Analytical methods for the quantitation of the drug in biological fluids may not be 
available,  
 Analytical methods for a drug in combination with other drugs may not be available,  
 The existing analytical procedures may require expensive reagents and solvents. It 
may also involve cumbersome extraction and separation procedures and these may 
not be reliable.  
Method development [5-7] 
• Planning 
• Method development 
• Customer evaluation testing  
• Validation experiments 
• Method transfer experiments  
• Final method in use 
• Final result 
 
CHROMATOGRAPHY [8, 9]  
Chromatography is a group of technique for the separation of the compounds of 
mixtures by their continuous distribution between two phases. One is stationary phase and the 
other is mobile phase.  As a general rule, highly polar materials are best separated using 
partition chromatography, while very non polar materials are separated using adsorption 
chromatography. Between extremes, either process might be applicable.  
Fig:  1 Schematic Diagram of a HPLC instrument  
 
 
HPLC Methods of Analysis for Drugs in Combination: 
         Most of the drugs in multi component dosage forms can be analyzed by HPLC method 
because of the several advantages like rapidity, specificity, accuracy, precision and ease of 
automation in this method. HPLC method eliminates tedious extraction and isolation 
procedures. Some of the advantages are:  
 Speed (analysis can be accomplished in 20 minutes or less),  
 Greater sensitivity (various detectors can be employed),  
 Improved resolution (wide variety of stationary phases),  
 Reusable columns (expensive columns but can be used for many analysis),  
 Ideal for the substances of low volatility,  
 Easy sample recovery, handling and maintenance,  
 Instrumentation tends itself to automation and quantitation (less time and less labour),  
 Precise and reproducible,  
 Calculations are done by integrator itself,  
 Suitable for preparative liquid chromatography on a much larger scale.  
The different types of chromatography 
9 Adsorption chromatography 
9 Partition chromatography 
9 Ion Exchange chromatography 
9 Gel permeation chromatography 
9 Column chromatography 
 
 
 
 
 
Table no: 1 CLASSIFICATION OF COLUMN CHROMATOGRAPHIC METHODS 
 
General classification 
 
Specific method 
 
Stationary phase 
 
Type of equilibrium
 
 
 
 
 
 
Liquid 
Chromatography 
(LC) (mobile phase: 
liquid) 
 
Liquid-Liquid 
or partition 
 
Liquid adsorbed 
on a solid 
 
Partition between 
immiscible 
liquids 
 
Liquid-Bonded 
Phase 
 
Organic species 
bonded to a solid 
surface 
 
Partition between 
liquid and bonded 
surface 
 
Liquid-Solid or 
Adsorption 
 
Solid 
 
Adsorption 
 
Ion exchange 
size exclusion 
 
Ion-exchange 
resin Liquid in 
interstices of a 
polymeric solid 
 
Ion exchange 
Partition/sieving 
 
Gas Chromatography 
(GC) (mobile phase: 
gas) 
 
Gas-liquid 
 
Liquid adsorbed 
on a solid 
 
Partition between 
gas and liquid 
  
Gas-bonded 
Phase 
 
Organic species 
bonded to a solid 
surface 
 
Partition between 
liquid and bonded 
surface 
 
Gas-Solid 
 
Solid 
 
Adsorption 
 
Supercritical-fluid 
chromatography 
(SFC) (mobile phase: 
Super critical fluid 
  
Organic species 
bonded to a solid 
surface 
 
Partition between 
supercritical fluid 
and bonded 
surface 
 
There are different modes of separation in HPLC. They are normal phase mode, 
reversed phase mode, reverse phase ion pair chromatography, affinity chromatography and 
size exclusion chromatography.  
            In the normal phase mode, the stationary phase is polar (bonded siloxane with a 
polar functional group-polarity order: cyano<diol< amino <dimethylamino) and the mobile 
phase is nonpolar (n-hexane, methylene chloride, or chloroform) in nature. Polar compounds 
are retained for longer times because of their higher affinity with the stationary phase. These 
compounds, therefore take more times to elute. Normal phase mode of separation is therefore, 
not generally used for pharmaceutical applications because most of the drug molecules are 
polar in nature and hence take longer time to elute.  
Reversed phase mode is the most popular mode for analytical and preparative separations of 
compound of interest in chemical, biological, pharmaceutical, food and biomedical sciences. 
In this mode, the stationary phase is non-polar hydrophobic packing with octyl or octadecyl 
functional group bonded to silica gel and the mobile phase is polar solvent (methanol, 
acetonitrile, tetrahydrofuran, water, or usually a mixture of water with one of the organic 
solvents).  
An aqueous mobile phase allows the use of secondary solute chemical equilibrium 
(such as ionization control, ion suppression, ion pairing and complexation) to control 
retention and selectivity and for adjusting the polarity. The organic solvent is called the 
modifier, and acetonitrile is the most common one.  
The polar compound gets eluted first in this mode and nonpolar compounds are 
retained for longer time. As most of the drugs and pharmaceuticals are polar in nature, they 
are not retained for longer times and hence elute faster. The different columns used are 
octadecylsilane (ODS) or C18, C8, C4, etc., (in the order of increasing polarity of the stationary 
phase).  
  Reverse phase chromatography is widely in use due to the following advantages. 
¾ Many compounds such as biologically active substances, have limited solubility in the 
nonpolar mobile phase that are employed in normal-phase chromatography. 
¾ Ionic or highly polar compounds have high rate of adsorption on straight silica or 
alumina columns and therefore can elute as tailing peaks. 
¾ Column deactivation from polar modifiers is a problem in liquid-solid 
chromatography which frequently can lead to irreproducibility in chromatographic 
systems. 
¾ Long re-equilibration times during gradient elution are common in adsorption 
chromatography. The use of reversed phase chromatography with bonded-phase 
columns is advantageous because of the short re-equilibration time required. 
¾ Ionic compounds can be chromatographed by using ion-exchange chromatography. 
This mode of chromatography is tedious because precise control of variables such as 
pH and ionic strength is required for reproducible chromatography. 
QUANTITATION: 
Quantitation Methods in HPLC: 
Peak height or peak area measurements only provide a response in terms of detector 
signal. This response must be related to the concentration or mass of the compound of 
interest. To accomplish this, some type of calibration must be performed.  
The four primary techniques for quantitation are  
1. Normalized peak area method 
2. External Standard method 
3. Internal Standard method 
4. Method of Standard addition 
1. Normalized peak area method: 
The area percent of any individual peak is referred to the normalized peak area. This 
technique is widely used to estimate the relative amounts of small impurities or degradation 
compounds in a purified material and in this method; the response factor for each component 
is identified. 
2. External Standard method:  
This method includes injection of both standard and unknown and the unknown is 
determined graphically from a calibration plot or numerically using response factors. 
A response factor (Rf) can be determined for each standard as follows 
 Rf =    Standard Area (Peak height)  
  Standard Concentration 
 
The external standard approach is preferred for most samples in HPLC that do not require 
extensive sample preparation. For good quantitation using external standards, the 
chromatographic conditions must remain constant during the separation of all standards and 
samples. External standards are often used to ensure that the total chromatographic system is 
performing properly and can provide reliable results. 
3. Internal Standard method: 
              A widely used technique of quantitation involves the addition of an internal standard 
to compensate for various analytical errors. In this approach, a known compound of a fixed 
concentration is added to the known amount of samples to give separate peaks in the 
chromatograms to compensate for the losses of the compounds of interest during sample 
pretreatment steps. Any loss of the component of interest will be accompanied by the loss of 
an equivalent fraction of the internal standard. The accuracy of this approach obviously 
dependence on the structural equivalence of the compounds of interest and the internal 
standard.  
The requirements for an internal standard are:  
 It must have a completely resolved peak with no interferences,  
 It must elute close to the compound of interest,  
 It must behave equivalent to the compound of interest for analysis like pretreatments, 
derivative formations, etc.  
 It must be added at a concentration that will produce a peak area or peak height ratio of 
about unity with the compound,  
 It must not be present in the original sample,  
 It must be stable, un reactive with sample components, column packing and the mobile 
phase and  
 It is desirable that this compound is commercially available in high purity.  
 The internal standard should be added to the sample prior to sample preparation 
procedure and homogenized with it. To be able to recalculate the concentration of a 
sample component in the original sample, we have to demonstrate first the response 
factor. The response factor (RF) is the ratio of peak areas of sample component (Ax) and 
the internal standard (AISTD) obtained by injecting the same quantity. It can be calculated 
by using the formula,  
 
 
STDIA
AxRf
..
=  
         On the basis of the response factor and strength of the internal standard (NISTD), the 
amount of the analyte in the original sample can be calculated using the formula,    
                                                                          STD
STDF
S xN
AR
AX .1
1.
=  
          The calculations described above can be used after proving the linearity of the 
calibration curve for the internal standard and the analytical reference standard of the 
compound of interest. When more than one component is to be analyzed from the sample, the 
response factor of each component should be determined in the calculations using similar 
formula.  
4. Method of Standard addition: 
The method of standard addition can be used to provide a calibration plot for 
quantitative analysis. It is most often used in trace analysis. An important aspect of the 
method of standard addition is that the response prior to spiking additional analytes should be 
high enough to provide a reasonable S/N ratio (>10), otherwise the result will have poor 
precision. 
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System Suitability: 
 System suitability testing is an integral part of analytical procedures.   
 The tests are based on the concept that the equipment, electronics, analytical operations 
and samples to be analyzed constitute an integral system that can be evaluated as such.  
 System suitability test parameters to be established for a particular procedure depend on 
the type of procedure being validated. 
          The peak resolution can be increased by using a more efficient column with higher 
theoretical plate number, N.  
              The parameters that are affected by the changes in chromatographic conditions, It 
includes the following parameters, but not necessarily to comply all the parameters. 
• Resolution (Rs), 
• Capacity factor (k’), 
• Selectivity (α), 
• Column efficiency (N) and 
• Peak asymmetry factor (As). 
i) Resolution (Rs) 
The resolution, Rs, of two neighboring peaks is defined by the ratio of the distance 
between the two peak maxima. It is the difference between the retention times of two solutes 
divided by their average peak width. For baseline separation, the ideal value of Rs is 1.5. It is 
calculated by using the formula, 
Rs = ( )21
12
5.0 WW
RtRt
+
−  
Where, Rt1 and Rt2 are the retention times of components 1 and 2 and  
             W1 and W2 are peak widths of components 1 and 2. 
ii) Capacity factor (k’) 
Capacity factor, k’, is defined as the ratio of the number of molecules of solute in the 
stationary phase to the number of molecules of the same in the mobile phase. Capacity factor 
is a measure of how well the sample molecule is retained by a column or TLC plate during an 
isocratic separation. The ideal value of k’ ranges from 2-10. Capacity factor can be 
determined by using the formula, 
K’   = S
V
VV ×−
0
01  
Where, V1 = retention volume at the apex of the peak (solute) and  
   V0 = void volume of the system. 
The values of k’ of individual band increase or decrease with changes in solvent 
strength. In reversed phase HPLC, solvent strength increases with the increase in the volume 
of organic phase in the water / organic mobile phase. Typically an increase in percentage of 
the organic phase by 10 % by volume will decrease k’ of the bands by a factor of 2-3.  
iii) Selectivity (α) 
The selectivity (or separation factor), α is a measure of relative retention of two 
components in a mixture. The ideal value of selectivity is 2. It can be calculated by using the 
formula,   
α = 
01
02
VV
VV
−
−
 
           Where, V0 is the void volume of the column and V2 and V1 are the retention    
volumes of the second and the first peak respectively. 
iv) Column efficiency (N) 
Efficiency, N, of a column is measured by the number of theoretical plates per meter. 
It is a measure of band spreading of a peak. Smaller the band spread, higher is the number of 
theoretical plates, indicating good column and system performance. Columns with N ranging 
from 2000 - 100,000 plates/meter are ideal for a good system. Efficiency is calculated by 
using the formula, 
N   =   2
2
16
W
Rt , 
Where, Rt is the retention time and W is the peak width. 
v) Peak asymmetry factor (As) 
Peak asymmetry factor, as, can be used as a criterion of column performance. The 
peak half width, b, of a peak at 10 % of the peak height, divided by the corresponding front 
half width, a, gives the asymmetry factor. 
As =
a
b  
For a well packed column, an asymmetry factor of 0.9 to 1.1 should be achievable. 
System Suitability Parameters and Recommendations (ICH Guidelines) 
Parameter                                 Recommendation 
Capacity Factor (k’)  the peak should be well-resolved from other peaks and  
                           the void volume, generally k’>2.0  
Repeatability    RSD </= 1% for N >/= 5 is desirable.  
Relative retention  not essential as long as the resolution is stated. 
Resolution (Rs)  Rs of > 2 between the peak of interest and the closest  
                                eluting potential interferent (impurity, excipients,   
              degradation product, internal standard, etc.  
Tailing Factor (T)  T of </= 2  
Theoretical Plates (N)  In general should be > 2000  
 
 
 
 
 
 VALIDATION OF ANALYTICAL METHOD: 
 
 
 INTRODUCTION: 
            Analytical method validation is the process of demonstrating that analytical 
procedures are suitable for their intended use and provide accurate test results that 
evaluate a product against its defined specification and quality attributes [10]. 
                            The U.S. Federal Register states “Validation data must be available to 
establish that the analytical procedures used in testing meets proper standards of accuracy 
and reliability [11]”any analytical test methods are expected to be used in a Quality Control 
environment they require an additional degree of refinement compared to research 
methods [12]. 
           The following observation will explain the relationship between validation and 
method development. 
¾ When methods are properly developed, they readily validate. 
¾ Validation is not a method development tool and it does not make a method good 
or efficient. 
¾ Validation acceptance criteria should be based on method development 
experience. 
   
VALIDATION OF ANALYTICAL PROCEDURES [13-17] 
Different Types of Validation characteristics [18] 
 
 
Generalized validation process for an HPLC assay method:  
    Validation is the process of collecting documented evidence that the method 
performs according to its intended purpose. 
1. Precision: 
          The closeness of agreement between a series of measurements multiple samplings 
of the same homogeneous sample under prescribed condition. 
 The precision of test method is usually expressed as the standard deviation or relative 
standard deviation of a series of measurements. 
 Precision may be considered at three levels: Repeatability, Intermediate Precision and 
Reproducibility. 
Acceptance Criteria: 
¾ Percentage Relative standard deviation (%RSD)  NMT 1 % (Instrument precision) 
¾ (%RSD)  NMT -2% (Intra- assay precision) 
2. Accuracy [19]: 
The ICH guideline recommends that accuracy should be determined using a minimum of nine 
determinations over a minimum of three concentration levels covering the specified range 
(ICH, 1996). Spiked samples are prepared in triplicate at three levels over a range that covers 
80 -120% of the target concentration for assay methods and over a range that covers the 
expected impurity content of a sample for impurity methods (Shabir, 2003). 
          There are several methods that can be used for determining accuracy. The most 
common include: 
          Analyze a sample of known concentration and compare the measurement to the true 
value. In this case, method accuracy is the agreement between the difference in the measured 
analyte concentration and the known amount of analyte added. That is the accuracy or % 
recovered is calculated as:  
                           Cm × 100     
       Ct 
 Where Cm is the measured concentration and Ct is the theoretical concentration.            
Accuracy has also been reported as a sample is analyzed and the measured value should 
ideally be identical to the true value. Accuracy is represented and determined by recovery 
experiments. The usual range is being 10% above or below the expected range of claim. The 
% recovery was calculated using the formula, 
100
)(covRe%
bX
abaery −+=  
 
Where, 
 a – Amount of drug present in sample 
 b – Amount of standard added to the sample 
  
 
Acceptance Criteria: 
¾ For an assay method, mean recovery will be 100%± 2% at each concentration over the  
range of 80-120% of the target concentration. 
¾ For an impurity method, mean recovery will be 0.1% absolute of the theoretical  
concentration or 10% relative, whichever is greater for impurities in the range of 0.1-2.5 % 
(V/W). 
3. Detection Limit: 
      It is lowest amount of analyte in a sample that can be detected but not necessarily 
quantitated under the stated experimental conditions.  
Following are different approaches: 
i. Visual Evaluation Method: 
      Prepare the sample solutions with known lowest possible concentrations of analyte and 
establish the minimum concentration at which the analyte can be reliably detected by 
analyzing as per test method. 
ii. Based on Signal to Noise Ratio Method: 
The LOD can be expressed as a concentration at specified signal-to-noise ratio obtained from 
samples spiked with analyte. A signal-to-noise ratio between 3:1 and 2:1 is generally 
considered acceptable. 
iii. Based on the standard Deviation of the Response and the Slope: 
¾  Prepare the blank solution as per test method and inject six times into the  
chromatographic system. 
¾ Similarly prepare the linearity solution staring from lowest possible concentration of  
analyte to 150 % (or as per protocol) of target concentration and establish the linearity  
curve. 
The detection limit (DL) may be expressed as: 
 
  3.3 X Standard deviation of the response of the blank (σ) 
       LOD   =   
                                                                          Slope 
 The slope shall be estimated from the calibration curve of the analyte. 
  
4. Quantitation Limit: 
It is lowest amount of analyte in a sample, which can be quantitatively determined with 
acceptable accuracy and precision. 
Following are different approaches:  
i. Visual Evaluation Method: 
            Prepare the sample solutions with known lowest possible concentrations of analyte 
and establish the minimum concentration at which the analyte can be reliably quantified by 
analyzing as per test method.  
ii. Based on signal to noise ratio method : 
 The LOQ can be expressed as a concentration at specified signal-to-noise ratio 
obtained from samples spiked with analyte. A signal-to-noise ratio of 10:1 is generally 
considered acceptable. The ratio recognized by the ICH (1996) is a general rule. It has been 
stated that “The determination of LOQ is a compromise between the concentration and the 
required precision and accuracy. That is, as the LOQ concentration level decreases, the 
precision increases”. 
iii. Based on the standard Deviation of the Response and the Slope: 
¾  Prepare the blank solution as per test method and inject six times into the  
chromatographic system. 
¾ Similarly prepare the linearity solution staring from lowest possible concentration of  
analyte to 150% (or as per protocol) of target concentration and establish the linearity  
curve. 
 
The Quantification limit (QL) may be expressed as: 
 
                                        10 X Standard deviation of the response of the blank (σ) 
                   LOQ =   
                                                                   Slope 
 The slope shall be estimated from the calibration curve of the analyte. 
  Perform the Precision and accuracy at the level of limit of 
quantification by spiking LOQ concentration on placebo / Drug product / Drug substance. 
 For detail methodology and acceptance criteria refer Precision and accuracy of       test 
method. 
Acceptance Criteria: 
¾ In Pharmaceutical application, the LOQ is typically set at minimum 0.05% for active  
pharmaceutical ingredients. 
¾ LOQ defined as the lowest concentration providing a RSD of 5%. 
LOQ should be at least 10% of the minimum effective concentration for clinical applications 
5. Specificity: 
 The ability to assess unequivocally the analyte in the presence of components that may be 
expected to present, such as impurities, degradation products and matrix components, etc. 
            Specificity shall be demonstrated by performing Placebo / blank interference and 
forced degradation studies. 
1. Blank interference:  
  Prepare blank solution as per test method and analyse as per test method. 
2. Placebo interference (In case of Drug products):  
 Prepare the placebo solution equivalent to the test concentration (Subtract the weight of 
active ingredient) and analyse as per test method. 
3. Force Degradation studies:  
 Degrade the sample forcefully under the various stress conditionslike Light, heat, 
humidity, acid / base / water hydrolysis and oxidation and ensure the degradation from 1 % to 
20 %. 
 Light: Expose the Drug product, drug substance and placebo to UV light for about 200 
watt hours / square meter and the overall illumination not less than 1.2 million Lu hours [17] 
for visible light. Prepare the sample and placebo solution as per test method and analyse. 
 Heat: Expose the Drug product, drug substance and placebo at   105 °C for about 12 
hours (For substance having low melting point below 10°C of its melting point). Prepare the 
sample and placebo solution as per test method and analyse. 
 Humidity: Expose the Drug product, drug substance and placebo for about 80 % RH at 
about 25°C for about one week. Prepare the sample and placebo solution as per test method 
and analyse. 
 Acid / Base: Prepare the acid or base solution of 0.1N and reflux the sample and placebo 
with 50 ml of acid / base solution for about 1 hour at 60°C. Neutralize the solution and 
dissolve the contents in diluents as per test method. Change the strength of acid and base or 
reflux time to ensure the desired degradation. 
 Water: Reflux the sample / placebo with 100 ml of purified water for 12 hour at 60°C. 
Dissolve the contents in diluents as per test method. Change the reflux time so as to ensure 
the desired degradation. 
 Oxidation: Reflux for 12 hour at 60°C with 1 % H2O2 or suitable oxidant. Dissolve the 
contents in diluents as per test method. Change the reflux time so as to ensure the desired 
degradation. 
Note: Based on the physicochemical properties and literature stress conditions can be  
     decided. 
Acceptance Criteria: 
¾ Placebo / Blank should not elute at the retention time of analyte peak and known impurity 
peak. 
¾ Peak purity of analyte peak should be confirmed. 
¾ Degradation of active analyte peak should be from 1% to 20%. 
 
6. Linearity and range:  
The linearity of an analytical method is its ability to elicit test results that are directly (or 
by a well defined mathematical transformation) proportional to the analyte concentration in 
samples within a given range. The linear range of detectability that obeys Beer’s law is 
dependent on the compound analyzed and the detector used. The working sample 
concentration and samples tested for accuracy should be in the linear range. The claim that 
the method is linear is to be justified with additional mention of zero intercept by processing 
data by linear least square regression. Data is processed by linear least square regression 
declaring the regression co-efficient and b of the linear equation, 
Y= aX + b 
together with the correlation coefficient of determination r. For the method to be linear the r 
value should be close to1. Where Y is the measured output signal, X is the concentration of 
sample, a is the slop, b is the intercept. 
            The range of an analytical method is the interval between the upper and lower levels 
of the analyte (including these levels) that have been demonstrated to be determined with 
precision, accuracy and linearity using the method as written.  
             If linearity is not meeting the acceptance criteria, establish the range of concentration 
in which it is linear. 
Acceptance criteria:  
 Coefficient of correlation should be NLT 0.99. 
7. Robustness: 
 It is a measure of method's ability to remain unaffected by small but deliberate variations 
in method parameters and provides an indication of its reliability during normal usage.  
                 For example a chromatographic method, the typical method parameters need to 
change deliberately and verify during method validation:  
 Flow rate   : (+/- 0.2ml/minutes). 
 Mobile phase composition          : (+/- 10% of organic phase). 
 Column oven temperature          : (+/- 5°C). 
 PH of buffer in mobile phase    : (+/- 0.2 units). 
 Filter suitability   : (At least two filters). 
For Variations:  
 1.  System suitability should meet the acceptance criteria as per test method.  
 2.  If system suitability doesn’t meet, narrow the variation range and carryout the 
experiment again to meet system suitability. 
8. Ruggedness: 
 The United States of Pharmacopeia (USP) defines Ruggedness as “the degree of 
reproducibility of test results obtained by the analysis of the same samples under a variety of 
normal test conditions, such as different labs, different analysts, and different lots of reagents. 
Ruggedness is a measure of Reproducibility of test results under normal, expected 
operational conditions from laboratory to laboratory and from analyst to analyst”.  
 The following are the typical method parameters need to be tested during method       
      validation:  
  Analyst-to-Analyst variability. 
  Column-to-Column variability. 
  System-to-System variability. 
  Different days. 
  Different Laboratories. 
  Stability of Solutions and mobile phase.  ( At least for 48 hours ) 
 
Method Validation Requirements for Example (ICH) 
Table no: 2 
 
Method Validation requirements                                 Acceptance Criteria 
 
Precision 
        Assay repeatability                                                     ≤ 1% RSD 
        Intermediate precision (Ruggedness)                          ≤ 2% RSD 
Accuracy 
        Mean recovery per concentration                              100.0% ± 2.0% 
Limit of detection 
        Signal to-to-noise ratio                                                   ≥ 3:1 
Limit of quantification   
        Signal to-to-noise ratio                                                   ≥ 10:1 
Linearity/Range 
        Correlation coefficient                                                    >0.99 
        y-Intercept                                                                      ± 10% 
        Visual                                                                             Linear 
Robustness 
        System suitability met                                                     yes 
        Solution stability                                                  ± 2% change from time zero 
Specificity 
      Resolution from main peak                                   >2 min. (retention time) 
 
 
 
 
 
 
 
REVIEW OF LITERATURE 
Vickie Tatum et al(2005) [20] have reported RP- HPLC assay method for All-trans 
retinoic acid. Chromatographic separation was achieved on an C18 reversed phase column 
Using 85% methanol and 15% 0.01 M sodium acetate buffer, pH 5.2, as the mobile phase and 
at a flow rate of 1.5 ml/min. Retinol, retinal, all-trans-retinoic acid and 13-cis-retinoic acid 
were eluted from a 5 μm C18 reversed-phase column (4.6mm I.D., 15 cm) in less than 14 
min. Retinyl acetate, was eluted in 25.5 min under the above conditions. Each compound was 
detected at the most sensitive wavelength by coupling fluorescence and UV detection. 
Lopez-Abater et al(2003) [21] have developed a method for the simultaneous 
determination of retinol acetate, α-Tocopherol and α-Tocopherol acetate. Method I: the fat 
milk sample was extracted with ethanol-hexane and injected directly into the 
chromatographic column. Method II: the power milk sample was extracted with ethanol-
hexane and also injected directly into the column. Under optimum conditions the limits of 
detection for retinol acetate, δ-, β-, α-Tocopherol and α-Tocopherol acetate were 0.33, 21.2, 
32.9, 32.5 and 3 .2 ng and the limits of quantification were 0.42, 25.3, 37.9, 36.8 and 6.3 ng, 
respectively. The precision results showed that the relative standard deviations of 
repeatability and reproducibility were between 0.74 and 5.7%. 
David J. Hart et al(1999) [22] have performed studies that  examine the factors which 
affect the chromatographic response of carotenoids and contribute to analytical variation and 
inaccuracies in their quantitative determination. The addition of a solvent modifier 
(triethylamine) to the mobile phase was shown to improve the recovery of carotenoids from 
the column from around 60% to over 90%. Analysis showed that good sources (>1000 
μg/100 g) of lutein were broccoli, butter head lettuce, parsley, peas, peppers, spinach and 
watercress; of lycopene: tomatoes and tomato products; and of β-carotene: broccoli, carrots, 
greens, butter head lettuce, mixed vegetables, parsley, spinach and watercress. There was 
little or no loss of carotenoids on cooking, green vegetables showed an average increase in 
lutein levels of 24% and in β-carotene levels of 38%.  
Erin M. Siegel et al(2001) [23] have been reported that retinoids have cancer 
chemotherapeutic and chemopreventive activities. Total RA concentration and the 
concentrations of RA isomers (all-trans-RA, 13-cis-RA, and 9-cis-RA) were measured by 
high-pressure liquid chromatography in serum samples. The relative abundance of the three 
RA isomers was similar for each visit with 13-cis-RA having the highest concentrations 
followed by 9-cis-RA and all-trans-RA. The within-person variability of total RA and 
individual isomers was low.  
Raphael Vazquez et al(2009) [24] have reported a RP-HPLC separation on an Zorbax 
C18 column (150 mm x 4.6 mm, 2.5 µm particle size)using a mobile phase consisting of a 
mixture ammonium acetate 10 mM, pH 4.5 (solvent A) and methanol (solvent B). The 
separation was achieved within 35 minutes and the detection was performed by UV 
spectrometry-tandem mass spectrometry. The validation of the method was performed by the 
statistical evaluation for intra-day (n =6) and inter-daycalibrations (n =7); it was found to be 
satisfactory in terms of selectivity, accuracy (recovery between 100.0 and 102.3%) and 
precision (intra-day and inter-day precision between 1.0 and 10.2% and between 0.7 and 
11.8%, respectively).  
Amin Ismail et al(2003) [25] have developed a RP-HPLC method for vitamin analysis, 
to identify and quantify β -carotene, vitamin C and riboflavin. A ultra sphere octa decyl silyl 
(ODS) hypersil C18, 5 mm particle size, in a 250 mm length x 4.0 mm I.D stainless steel 
column is used with a mobile phase mixture of acetonitrile: methanol: ethyl acetate (88:10:2). 
Flow rate of 1ml/min is maintained. UV detection at detection at 250nm. 
A.M dzerk et al(1998) [26] have been  developed a  RP-HPLC method for the 
quantitation of 9-cis-retinoic acid and its major metabolite, 4-oxo-9-cis-retinoic acid in 
human plasma. Samples were buffered and extracted with methyl-tert-butyl-ether. The 
analytes and an I.S. were separated on a C18 HPLC column using a shallow gradient of 70–
89% organic solvent. The analytes were quantitated by UV detection at 348 nm. Selectivity 
against endogenous compounds and potential metabolites was demonstrated. The run time 
was 29 min. The standard curve was linear from 2.5 to 450 ng/ml. Inter assay precision for 
both analytes in quality control samples was less than 5.0% RSD.  
Prachikabra et al(2003) [27] have developed a RP-HPLC method and validated for 
the determination of Isotretinoin in pharmaceutical dosage form. Chromatographic separation 
was carried out on a C-8 column using a mobile phase consisting of acetonitrile: isopropyl 
alcohol (50:50, v/v) adjusted at pH 5.0 using 1% ortho phosphoric acid. Flow rate was 1ml/ 
min and UV detection was carried at 280 nm. Caffeine was used as an internal standard. The 
calibration curve was linear over the range 5–600µgml−1. R.S.D. for precision study was 
found to be <1%. The result of accuracy study was ranged between 98.61% and 101.51% 
with a R.S.D. lower than 2%. LOD and LOQ were found to be 0.0428µgml−1 and 
0.1298µgml−1, respectively.  
Lopez LB et al(2002) [28] have been developed a methodology for the quantification 
of vitamin A in human milk. Vitamin A levels were assessed in 223 samples corresponding to 
the 5th, 6th and 7th postpartum months. The samples were saponified with potassium 
hydroxide/ethanol, extracted with hexane, evaporated to dryness and reconstituted with 
methanol. A column RP-C18, a mobile phase methanol/water (91:9 v/v) and a fluorescence 
detector (lambda excitation 330 nm and lambda emission 470 nm) were used for the 
separation and quantification of vitamin A. The analytical parameters of linearity (r2: 
0.9995), detection (0.010 microg/ml) and quantification (0.025 microg/ml) limits, precision 
of the method (relative standard deviation, RSD = 9.0% within a day and RSD = 8.9% among 
days) and accuracy (recovery = 83.8%) demonstrate that the developed method allows the 
quantification of vitamin A in an efficient way.  
Prachikabra et al(2000) [29] have developed a simple, sensitive and specific UV 
spectrophotometric for the estimation of isotretinoin in bulk and soft gelatin capsule for 
routine analysis. The optimum conditions for analysis were established and validated in 
conformance with ICH guidelines. It was observed, the absorbance maximum (λmax) for 
Isotretinoin was 344 nm in methanol and the linearity was in the range of 1-8 μg/ml with 
coefficient of correlation as 0.9994. The lower limit of detection and the limit of 
quantification were found to be 0.2519 and 0.7634μg/ml respectively. 
Stephen A. Barnett et al(1979) [30] have developed a RP-HPLC method for the 
simultaneous estimation of Vitamin A acetate Vitamin D2 and Vitamin E acetate in 
multivitamin mineral tablets. The method requires dissolution of the sample in water-ethanol-
pyridine solution (50:46:4), extraction of the vitamin in to warm hexane addition of 
cholesterol benzolate internally standard and separation with a methanol water gradient 
solution of coupled µBond pack phenyl-µbond pack column. Detection of the vitamin and 
internal standard is monitored at 280nm with separation accomplished in approximately in 
15mn.  
 Clyde A. Collins et al(2001) [31] have developed a rapid and sensitive RP-HPLC 
method with fluorescence detection for the analysis for vitamin A and its acetate. The method 
employs a C18 reversed-phase column and methanol as an eluent. The detection of these two 
compounds is monitored with fluorescence excitation at 348 nm and emission at 470 nm. 
Detector noise established the lower limit of quantitation at approximately 0.5 ng. Plasma 
samples were employed to evaluate the accuracy, reproducibility, and applicability of the 
method. Less than 1 ng of vitamin A in plasma can be quantitated by this procedure. 
  Zafar Iqbala et al(2001) [32] have developed a novel, simple and fast reversed-
phase HPLC/UV method for simultaneous determination of all-trans-retinol and α-
Tocopherol in human serum using Retinyl acetate as internal standard in the concentration of 
0.5 μg/ml. A liquid-phase extraction was applied to the 250 μl of serum with n-hexane–
dichloromethane mixture (70:30, v/v), in two steps, using ethanol–methanol mixture (95:5, 
v/v) for protein precipitation and BHT (butylated hydroxy toluene) as stabilizer for sample 
preparation. Both analytes were analyzed on Kromasil 100 C18 column (150 mm × 4.6 mm, 
5 μm), protected by a Perkin Elmer C18 (30 mm × 4.6 mm, 10 μm; Norwalk, USA) pre-
column guard cartridge, at 292 nm wavelength, using methanol–water (99:1, v/v), in isocratic 
mode as mobile phase applied at flow rate of 1.5 ml/min and 1 ml/min for both 5 μm and 
3 μm columns, respectively. Complete separation of all the analytes was achieved in 3 and 
6 min on 3 μm and 5 μm columns.  
Lorena Rigogaspar et al(2010) [33] have reported  a simple RP-HPLC method to 
evaluate the influence of two currently available photostabilizers on cosmetic formulations 
containing combined UV-filters and vitamins A and E. UV-irradiated formulation samples 
were submitted to a procedure that included a reliable, precise and specific HPLC method 
employing a C18 column and detection at 325 and 235 nm. Methanol, isopropanol and water 
were the mobile phases in gradient elution. The method precision was between 0.28 and 5.07.  
Benedicte Morina  et  al(2007)[34] have reported the effect of the fat-soluble 
vitamin A or vitamin E and grape seed proanthocyanidin extract (GSPE) on oxidative DNA 
damage estimated by 8-oxo-7, 8-dihydro-2′-deoxyguanosine (8-oxodG) contents in urine and 
leukocyte of rats. The aim of this study was to establish whether anthocyanidins could act as 
putative antioxidant micronutrients.  
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PLANT PROFILE-1  
Description of plant: Broccoli 
Botanical information: 
Botanical name    : Brassica oleracea. 
Family        : Brassicaceae 
 
Fig: 3 Brassica oleracea 
Common names  : Broccoli, brocks, calabrese, Italian asparagus, Italian broccoli 
Vernacular names: 
Hindi  : Hari phulagobi 
Tamil  : pachchai pookosu  
Parts used : whole plant 
Chemical constituents: 
Broccoli is high in vitamin C, as well as dietary fiber; it also contains multiple 
nutrients with potent anti-cancer properties, such as di-indolylmethane and small amounts 
of selenium. It also contains the compound glucoraphanin, which can be processed into an 
anti-cancer compound sulforaphane, and an excellent source of indole-3-carbinol, a chemical 
which boosts DNA repair in cells and appears to block the growth of cancer cells. Broccoli 
has the highest levels of carotenoids in the brassica family. It is particularly rich in lutein and 
also provides a modest amount of beta-carotene. 
 
Uses: 
It is a potent modulator of the innate immune response system with anti-viral, anti-
bacterial and anti-cancer activity. Indole-3-carbinol, a chemical which present in boosts DNA 
repair in cells and appears to block the growth of cancer cells. A high intake of broccoli has 
been found to reduce the risk of aggressive prostate cancer. Broccoli consumption has also 
been shown to be beneficial in the prevention of heart disease. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PLANT PROFILE-2 
 
Fig: 4 Spinacia oleracea 
Description of plant: Spinach 
Botanical information: 
Botanical name    : Spinacia oleracea. 
Family       : Amaranthaceae, formerly Chenopodiaceae Mimosaceae 
Habitat                 : Asia, probably Persia 
Vernacular names: 
Hindi           : Palak 
Marathi      : Palak 
Malayalam : cheera, bayala 
Sanskrit      : Palakya 
Tamil          : Pasalakeerai 
Parts used  : Leaves 
 
 
Chemical constituents: 
Spinach leaves, containing several active components, including flavonoids, exhibit 
antioxidative, antiproliferative, and anti-inflammatory properties in biological systems. A 
powerful, water-soluble, natural antioxidant mixture (NAO), which specifically inhibits the 
lipoxygenase enzyme, was isolated from spinach leaves. Spinach contains an impressive 
range of active substances which are indispensable to the body. In its structure we find 
mineral salts (sodium, potassium, calcium, phosphorus, magnesium, sulfur, iron, zinc, 
manganese, and iodine, copper), vitamins (C, B1, B2, B6, PP, E, K, folic acid, vitamin A), 
chlorophyll, amino acids such as arginine and lysine, but also lipids, and fibers. With only 17 
calories, 100 grams of spinach supplies the body with 5 mg of iron, 500 mg of potassium, 170 
mg of calcium, 23 mg of vitamin C, 2 mg of vitamin E, 150 micrograms of folic acid, 3500 
micrograms of beta-carotene and 7 grams of alimentary fibers. 
Uses: 
The plant is used against throat and lung affections.   
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                AIM AND OBJECTIVE 
The use of All-trans retinoic acid in health prospects is growing enormous, a study to 
investigate the estimation of the All-trans retinoic acid which is widely used as an Anti-
oxidant, in Broccoli (Brassica oleracea) and Spinach (Spinacia oleracea) extract has been 
proposed. There is no validated RP-HPLC method reported for the estimation of All-trans 
retinoic acid present in the plant Broccoli  (Brassica oleracea) and Spinach (Spinacia 
oleracea). 
Hence the present study was aimed to 
¾ Develop a new RP- HPLC method for the estimation of All-trans retinoic acid in 
different extract of these plants. 
¾ Validate the developed method as per ICH guidelines. 
¾ And to quantify All-trans retinoic acid in extract of these plants and dried leaves of 
the same. 
  For the simultaneous estimation of All-trans retinoic acid in extracts HPLC, HPTLC and 
UV-Spectroscopic methods are considered to be the most suitable. These methods are 
powerful, extremely precise, accurate, sensitive, specific, linear and rapid in analyzing the 
sample.    
For the estimation of the drugs present in the extracts, RP-HPLC method is considered to 
be more suitable since this is a powerful and rugged method. In this study, HPLC with PDA 
detector was used the estimation of All-trans retinoic acid in Broccoli and Spinach. 
 
 
 
 
 
 
 
 
MATERIALS 
 
Plant materials 
  Broccoli and Spinach was obtained from Hills  area of Ooty, Tamil nadu. 
Marker compounds 
All-trans retinoic acid was purchased from Surien Pharmaceutical Pvt.Ltd Chennai 
(India). The purity of All Trans retinoic acid was reported to be 99.6% w/w. 
Chemicals and Solvents  
 Acetonitrile HPLC grade    –  Merck specialties, Mumbai. 
 Ortho phosphoric acid (Analytical grade)  –  SD fine chemicals, Mumbai. 
 Distilled water     –  Merck specialties, Mumbai. 
Instruments  
• HPLC system (Shimadzu, Japan) with LCsolution software. 
 
• Elico pH meter LI 127. 
• Shimadzu LC-20 AT HPLC. 
  System      : Shimadzu gradient HPLC 
Pump        : LC – 20AT prominence solvent delivery system 
  Detector    : SPD-M20A Prominence Diode array detector 
  Injector     : Rheodyne 7725i with 20 μl loop 
• Shimadzu 1600 LC-UV Spectrophotometer. 
• Solvent filtration unit – Millipore. 
• Shimadzu electronic balance AY 220. 
• Ultra Cooling centrifuge – Remi, IndiaPerkin elmer Lambda 25 UV/Vis  
                                           spectrophotometer with win lab software. 
• Branson 1510 sonicator.  
• Solvent filtration unit – Millipore. 
• Mettler AT 200 weighing balance. 
• Prama rotatory evaporator 
       
 
                          METHODOLOGY 
Selection of wavelength 
Accurately weighed (1 mg) of All-trans retinoic acid was transferred in to a separate 
volumetric flask and dissolved in 10 ml methanol to produce 100 µg/ml of stock solution. A 
working standard solution containing 10µg/ml was prepared and the UV spectrum was 
recorded by scanning in the range of 200 nm to 400 nm. The chromatographic conditions 
used for the initial run is given below, 
9 Chromatographic conditions-1  
  Stationary phase : Phenomenex C18 column 
Mobile phase  : Solvent A: hexane sulphonic acid pH 3.5                                               
                                                 Solvent B:  methanol 
Solvent ratio  : 50:50 
Detection  : 215 nm 
Flow rate  : 1.0 ml/min 
Sample size  : 20 μl 
Needle wash  : water  
Column temperature   : room temperature (20ºC) 
9 Chromatographic conditions-2  
Stationary phase         : Phenomenex C18 column 
Mobile phase             : Solvent A: potassium dihydrogen orthophosphate 
                                     20mM pH 3.5, Solvent B:  acetonitrile  
Solvent ratio              : 60:40 
Detection                  : 261 nm 
Flow rate                  : 1.0 ml/min 
Sample size              : 20 μl 
Needle wash             : water  
Column temperature  : room temperature (20ºC) 
9 Chromatographic conditions-3  
Stationary phase  : Phenomenex C18 Column 
Mobile phase  : Solvent A: Water 
                                         Solvent B: acetonitrile  
Solvent ratio  : 60:40 
Detection  : 220 nm 
Flow rate  : 1.0 ml/min 
Sample size  : 20 μl 
Needle wash  : water  
Column temperature : room temperature (20ºC) 
9 Chromatographic conditions-4 
Stationary phase  : Phenomenex C18 Column 
Mobile phase  : Solvent A: ortho phosphoric acid pH-4                                         
                                        Solvent B:  acetonitrile: methanol (50:50) 
Solvent ratio  : 55:45 
Detection  : 201 nm 
Flow rate  : 1.0 ml/min 
Sample size  : 20 μl 
Needle wash  : water  
Column temperature : room temperature (20ºC) 
 
 
 
While developing RP-HPLC method with different mobile phases like acetonitrile: 
methanol, acetonitrile: buffer (acetate, phosphate buffer), and methanol: buffer was used, but 
no favourable results obtained. But the mobile phase consisting of ortho phosphoric acid and 
acetonitrile in the ratio 55:45 gave acceptable peak.   
            Hence, further modification was made in the mobile phase to get a sharp symmetrical 
peak with good resolution. 
4) OPTIMIZATION OF SEPARATION CONDITIONS  
• Effect of ratio of mobile phase 
 The mobile phase of ortho phosphoric acid and acetonitrile in various ratios, 50:55, 
55:45, 60:40, 70:30,   were tried and the chromatograms were recorded at 201 nm with a flow 
rate of 1ml/min. At the ratio of 55:45 of ortho phosphoric acid and acetonitrile was selected 
as the ideal ratio for the estimation of All-trans retinoic acid. 
• Effect of flow rate: 
 Keeping the ortho phosphoric acid and acetonitrile mobile phase ratio at 55:45 
chromatograms were recorded at a flow rate of 1ml/min. At this flow rate, the peaks were 
sharp with good resolution. So 1ml/min was kept constant for the analysis (flow rate 
1.0ml/min 1.1ml/min, up to 1.5ml/min were also tried, but did not give any satisfactory 
results). 
Fixed chromatographic conditions: 
Based on the above studies, the following chromatographic conditions were finally optimized 
for the simultaneous estimation of All-trans retinoic acid in Broccoli (flower head) and 
Spinach  (leaf) extract. 
Stationary phase  : Phenomenex C18 column 
Mobile phase  : Solvent A: ortho phosphoric acid pH4 
                                         Solvent B:  acetonitrile 
Solvent ratio  : 55:45 
Detection  : 201 nm 
Flow rate  : 1.0 ml/min 
Sample size  : 20 μl 
Needle wash  : water  
Column temperature : room temperature (20ºC) 
 
SELECTION OF EXTRACTION PROCEDURE FOR THE PLANTS: 
EXTRACTION PROCEDUREOF BROCCOLI 
Method I. 
Weighed accurately about 10gm of sample(broccoli) in a beaker, then 30ml of hexane was 
added and stored in room temperature for two days. Filter the sample solution and take 10 ml 
of filtrate (hexane layer), to this 30ml of  di-chloride methane was added and kept for 2 days 
in room temperature. finally separated the two layers. 
Method II. 
 To the weighed sample of broccoli (10gm), 20ml of chloroform was added and Stored 
at room temperature for two days. Filter the sample solution and collected the filtrate. 
Method III. 
 10 gms of broccoli flowers was homogenized in a analytical grinder, added 50 ml of 
pure water and mixed allowed to autolyze for 2hrs at 25˚C to form a paste. This paste was 
extracted with ethyl acetate which were combined and dried at 35˚C under vacuum rotary 
evaporator. This residue was dissolved in 50ml of 10% ethanolic in water and washed 3 times 
with equal volume hexane to remove the Non-polar contaminants. Now this Ethyl acetate 
extract was washed with equal volume of ethyl acetate. This Ethyl acetate extract layer was 
pooled over anhydrous sodium sulphate and filtered through a 0.45µm membrane; filtrate 
was dried at 35˚C under vacuum in a rotary evaporator. This residue was dissolved in 
measured volume of methanol solvent. 
 
 
 
 
 
 
EXTRACTIONPROCEDUREFOR SPINACH: 
Method I. 
Accurately weighed sample of spinach was shaken with dry ether for 3 hours at room 
temperature. Collected residue was then extracted with two successive lots of dry acetone. 
Combine the filtrate of ether and acetone extracts and removed the solvent by evaporation. 
Method II. 
Weighed sample of spinach was shaken with toluene at room temperature. Then collected 
residue was extracted with two successive amount of methanol. Combine the extracts after 
filtration and removed the solvent by evaporation. 
Method III. 
Weigh about 0.5 – 1.0 g of fresh spinach leaves (avoid using stems or thick veins). 
Cut or tear the spinach leaves into small pieces and placed in a mortar along with 2.0 ml of 
acetone. Grind with a pestle until the spinach leaves have been broken into particles. Using a 
Pasteur pipette or spatula, transfer the mixture to a centrifuge tube. Rinse the mortar and 
pestle with 2.0 ml of cold acetone, and transferred the remaining mixture to the centrifuge 
tube. Cap tightly. Added 2.0 ml of hexane to the centrifuge tube, and shaken the mixture 
thoroughly. The separated hexane layer (dark green pigment layer) is transferred into a clean 
test tube. Traces of water remained in the solution is removed before separating the 
components through chromatography by the addition of 0.5g of anhydrous sodium sulphate. 
After standing for 5 minutes, transfer the liquid into another clean test tube.  
 
 
 
 
 
 
 
QUANTIFICATION AND VALIDATION 
Preparation of standard stock solutions  
Accurately weighed 10 mg of All-trans retinoic acid, transferred into a 10 ml volumetric 
flask, dissolved in 10ml of methanol, to produce 1 mg/ml stock solution. 
Preparation of working standard stock solutions  
 
Calibration curves 
Appropriate aliquots from the standard solutions were transferred to a series of 10 ml 
volumetric flasks, and the volume in each flask was adjusted to the mark with Mobile phase. 
The resulting concentrations of All-trans retinoic acid in the flasks ranged from 10-50 µg/ml. 
 
PREPARATION OF PLANT EXTRACTS 
Preparation of sample solution   
10 mg of plant extract was weighed accurately and transferred into china dish to 
remove hexane by evaporation and make up to 10ml in volumetric flask, with mobile phase.  
All the above solutions were filtered through 0.45 µm nylon filter paper prior to use. 
 
Recording of chromatogram  
With the optimized chromatographic conditions mentioned above, perform a steady baseline 
for about 20 min. After the stabilization of the baseline for about 20 min, the standard 
solution were injected and chromatograms were recorded until the reproducibility of the peak 
areas were found satisfactory and finally 10 μg/ml of the standard solution of the All-trans 
retinoic acid and Standard solutions containing 10-50µg/ml of same standard were injected 
and chromatograms were recorded. .Retention time of All-trans retinoic acid was found to be 
8.8 shown in Fig. 5, 6, 7, 8 and 9 respectively.  
The procedure was repeated using for the sample (extract) solutions and the 
chromatograms were shown in Fig.11, 12, 13, 14, 15, 16. Peak areas of the sample 
chromatograms were recorded and the amount of All-trans retinoic acid was calculated from 
the regression equation. 
 
 
 
VALIDATION OF THE HPLC METHOD 
 
The method was validated for linearity, accuracy, precision, robustness, sensitivity, 
system suitability, LOD and LOQ as per ICH guidelines (1996) by the following procedures 
System suitability 
System suitability of method was performed by six replicate analysis of the system 
suitability solution of All-trans retinoic acid. The acceptance criterion was ±2% for the 
percentage relative standard deviation (%RSD) of peak area and retention time. The 
resolution and number of theoretical plates and HETP were also determined. 
Specificity 
Specificity is the ability of an analytical method to differentiate and quantify the 
analyte in presence of other components in the sample. Peak purity of the method was 
evaluated by calculating the difference between peak angle (θp) and peak threshold angle 
(θth). If θp<θth, the peak is considered spectrally homogeneous; otherwise the peak is 
influenced by the presence (i.e., additional absorption) of another substance. Peak purity was 
assessed by using LC Solution software for the HPLC/PDA system based on the degree of 
similarity of UV spectra across the peak in the range of 190-800 nm. The separation was 
performed on a Phenomenex C18 column (particle size 5 µm; 250×4.6 mm, id). Peak purity 
evaluation was performed with the objective of obtaining additional supportive information 
during the selection of appropriate analytical conditions that allowed specific determination 
of All-trans retinoic acid.   
Linearity (Calibration curve) 
Linearity was performed for All-trans retinoic acid standard solutions in the 
concentration range of 10-50 µg/ml. Calibration curves were constructed by plotting peak 
areas against analyte concentrations. The linearity was assessed by calculating the slope, y-
intercept and coefficient of determination (r2) using Microsoft Excel 2007 program. 
 
Precision 
The precision of the method was examined by performing the intra-day and inter-day 
assays of six replicate injections of the standard solution. The intra-day assay precision test 
was performed at intervals of 4 h in 1 day, while the inter-day assay precision test was 
performed over 6 days. 
 
 
  
Limits of detection (LOD) and quantification (LOQ) 
LOD and LOQ of the analyte was determined by k SD/b where k is a constant (3.3 for 
LOD and 10 for LOQ), SD is the standard deviation of the analytical signal, and b is the slope 
of the concentration/response graph. 
 
Accuracy 
The accuracy of the method was determined by calculating the recoveries of All-trans 
retinoic acid by the method of standard addition. Known amount of the standards (80, 100 
and 120%) were spiked in to the pre-analyzed sample solutions, and the amounts of these 
standards were estimated by measuring the peak areas and by fitting these values to the 
straight-line equation of calibration curves. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 RESULTS AND DISCUSSION 
HPLC METHOD 
A RP-HPLC method was developed for the estimation of All-trans retinoic acid in 
Broccoli (Brassica oleracea) and Spinach (Spinacia oleracea) extract. The chromatographic 
conditions were stabilized in order to provide a good performance of the assay. The standard 
and sample solutions were prepared and chromatograms were recorded. This project proposes 
a method for the determination of All-trans retinoic acid in Broccoli  (Brassica oleracea) and  
Spinach  (Spinacia oleracea) extract.  
Method validation 
The method was developed for analyzing All-trans retinoic and validated for linearity, 
accuracy, precision, LOD, LOQ, robustness and system suitability as per ICH guidelines. 
System suitability 
Six replicate injections of the system suitability solution gave %RSD values for 
retention time and peak area within 2%, indicating low variation of the measured values 
(Table 6). The symmetry of all peaks was < 2. The resolution (R) of All-trans retinoic acid, 
indicating a high degree of peak separation (R>2). The efficiency of the column, as expressed 
by the number of theoretical plates, was more than 2000. These results indicate the suitability 
of the RP-HPLC system and conditions of the developed method. 
Calibration curve (Linearity) 
Five working standard solutions of All-trans retinoic acid in the range of 10-50 µg/ml 
were prepared respectively. Each solution was injected in six replicate and the linear 
regressions analysis of All-trans retinoic acid  were constructed by plotting the peak area of 
the analyte (y) versus analyte concentration (µg /ml) on (x) axis. The slopes, y-intercepts and 
correlation coefficients (r2) obtained from regression analysis are shown in Table 3, Figure 
23. The regression equation was y=8315.1x+5040.1(r2 =0.999) for All-trans retinoic acid. 
 
Precision 
The intra-day and inter-day precision result for All-trans retinoic acids at the three 
concentrations are presented in Table 4, 5. Intra-day assay precision was performed at an 
interval of 4 h, whereas inter-day assay precision was performed over 6 days for All-trans 
Retinoic acid.  It was shown that the %RSD values for retention time of analyte was< 1%, 
while the %RSD values for peak area of analyte was< 2%. The low values of %RSD (<2%) 
reflected the high precision of the method. 
Accuracy 
As shown in Table5, the recovery of the investigated components ranged from 
100.37-100.94 and their %RSD values were all < 2%. It was known from recovery tests that 
all percentage recoveries were within 98-102%, indicating the good accuracy of the 
developed method. 
Limit of detection and Limit of quantification 
The LOD was found to be 40µg/ml and the LOQ was found to be 120 µg/ml for All-
trans retinoic acid (Table no: 6). These results indicated that the method provided adequate 
sensitivity. 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SELECTION OF EXTRACT 
 
 
  Trial   chromatogram of Broccoli extraction method I procedure 
 
 
 
 
Trail  chromatogram of Broccoli method II procedure 
 
  
Trail chromatogram of Spinach method I procedure 
 
Trail chromatogram of Spinach method II procedure 
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Fig: 11 Chromatogram of Broccoli (flower head) extract (40days) 
 
Fig: 12 Chromatogram of Broccoli (flower head) extract (45days) 
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 Fig: 17 UV spectrum of All-trans retinoic acid standard solution 
 
 
              Fig: 18 purity profile of All-trans of retinoic acid (10 µg/ml)  
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         Fig: 19 UV spectrum of Broccoli  (flower head)  extract 
 
 
 Fig: 20 purity profile of Broccoli flower head extract 
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 Fig: 21 UV spectrum of Spinach  leaf extract 
 
 
Fig: 22 purity profile of Spinach  leaf extract 
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LINEARITY RANGE OF ALL-TRANS RETINOIC ACID 
Table: 3 Calibration standard peak area 
S.NO  Con of 
drug(µg/ml) 
peak area 
1  10  91176 
2  20  174576 
3  30  255657 
4  40 338880
5  50 417220
 
 
Fig: 23 Linearity curve of All‐trans retinoic acid 
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Accuracy and Precision Studies (intraday) 
Table no: 4 Accuracy and Precision Studies (Intra - Day) 
S.No  Conc of 
drug(µg/ml) 
Mean peak 
area 
%Accuracy  %RSD 
1  10  91156  101.01  0.86 
2  20  174536  101.04  0.87 
3  30  254657  100.24  0.88 
4  40  337680  100.18 0.85
5  50  417220  99.30  0.81 
 
 
 
Table no: 5 Accuracy precision studies(inter-day) 
 
 
 
 
 
 
 
Table no: 6 System suitabilities studies 
S.NO  PARAMETERS  All‐trans 
retinoic acid 
1  Theoritical plate  7162.234 
2  HETP  28.943 
3  Tailing factor  0.953
4  LOD(µg/ml)  40 
5  LOQ(µg/ml)  120 
6  Resolution  1.206
7  K  0.952 
 
 
 
 
 
S.No  Conc. of 
drug(µg/ml) 
Mean peak 
area 
%Accuracy  %RSD 
1  10  91176  100.82  0.85 
2  20  174576 100.94 0.86
3  30  255657  100.46  0.85 
4  40  338880  100.37  0.84 
5  50  417220  99.14  0.83 
 
 
Recovery study of All-trans retinoic acid  
Table no:7 Recovery studies 
Components  Quantity 
added % 
Total quantity 
present, µg/ml 
Quantity 
found, µg/ml 
Recovery, %  %RSD 
 
All‐trans 
retinoic acid 
0  9.669  9.435  97.52  0.712 
80  17.844  17.669  98.97  0.642 
100  18.938  18.838  97.88  0.768 
120  20.831  20.455  98.19  1.664 
 
 
Table no: 8 Ruggedness studies 
Marker 
compound 
Name of 
analyst 
Concentration Mean peak 
area 
%RSD 
 
All-trans 
retinoic acid 
Day-1 Analyst-1 10µg/ml 91176 0.85 
Day-1 Analyst-2 10µg/ml 91181 0.87 
 
Quantification studies: 
Quantitation of All-trans retinoic acid in plant extracts: 
 
Table: 9a Quantification studies 
Components No. of 
weeks 
 Ethyl acetate flower head 
extract of                 
Broccoli  mg/g 
 
All-trans 
retinoic acid 
5th 0.04 
51/2 0.07 
6th 0.08 
 
 
Table:9b Quantification studies 
Components No. of weeks  Hexane leaf extract of 
Spinach  mg/g 
 
All-trans 
retinoic acid 
3rd 0.170 
31/2 0.250 
4th 0.370 
Dried leaves 0.364 
 
 
SUMMARY AND CONCLUSION 
The developed RP-HPLC method allows rapid and precise determination of All-trans 
retinoic acid content in Broccoli ( Brassica oleracea) and Spinach  (Spinacia oleracea) extract 
with an economical mobile phase. All-trans retinoic acid was higher in 6th week crop 
(0.08mg) of Broccoli ( Brassica oleracea) and 4th week crop (0.370mg) of Spinach ( Spinacia 
oleracea). 
The scope of the present work is to expand the optimization of the chromatographic 
conditions, to develop RP-HPLC method, a series of mobile phases were tried, among the 
various mobile phases ortho phosphoric acid and acetonitrile mixture (55:45) was found to be 
an ideal mobile phase, since it gave a good resolution and peak shapes with perfect 
optimization. The flow rate was optimized at 1 ml/min.  
The Linearity and correlation coefficient of All-trans retinoic acid was found to be 10-50 
µg/ml  0.9998 respectively.  
The limit of detection for All-trans retinoic acid was found to be 40 µg/ml and the limit of 
quantification was found to be 120 µg/ml. 
The method was known to be accurate with %recoveries ranging from 97.52 to 98.97%.  
The accuracy and precision study was performed at two levels intra-day and inter-day. The 
developed method showed good accuracy and precision. The inter-day accuracy ranges 
between 99.14-100.94% with %RSD between 0.83-0.86. The intra-day accuracy range 
between 99.30-100.24% with %RSD between 0.81-0.87. 
The isocratic elution technique developed for the determination of All-trans retinoic acid in  
Broccoli (Brassica oleracea) and Spinach ( Spinacia oleracea) extract is ideally suited for 
rapid and routine analysis. This method shows good reproducibility of the results. 
Furthermore this method was simple, sensitive, accurate and can be applied to all kinds of 
plant extract. 
 
 
 
CONCULSION 
The RP-HPLC method for analysis of All-trans retinoic acid in  Broccoli (Brassica 
oleracea) and Spinach  (Spinacia oleracea) extract was found to be accurate and precise. The 
proposed method was validated according to ICH guidelines and correlating the obtained 
values with the standard values, satisfactory results were obtained. 
Since the Anti oxidant Compound have been of interest in health benefits, this Project 
can be useful for further research of All-trans retinoic acid in other plant extracts also. 
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RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR THE 
ESTIMATION OF ALL-TRANS RETINOIC ACID IN PLANT EXTRACT OF 
BROCCOLI AND SPINACH. 
Abstract 
A simple high-performance liquid chromatography method using a photo diode array detector 
(PDA) is developed for the estimation of All-trans retinoic acid in plant extract of Broccoli 
and Spinach. The optimal analytical conditions are investigated to obtain the best resolution 
and the highest UV sensitivity for the quantitative detection of All-trans retinoic acid. The 
optimized conditions (acetonitrile : ortho phosphoric acid buffer, pH 4, isocratic elution 
system on a C18 reversed-phase column with a flow rate of 1 ml/min and UV absorbance at 
201 nm) allowed a specific and repeatable separation of the studied analyte to be achieved. 
Elution is successfully achieved within 9 min. Calibration curves are linear in 10-50 µ/ml 
range. The limit of detection and limit of quantitation limit values were found to be 40µ/ml 
and 120µl respectively. The validated method is applied to the determination of the specific 
phyto chemical markers All-trans retinoic acid in Broccoli and Spinach extracts. The 
recovery values ranged between 97.52 to 98.97%. The described HPLC method appears 
suitable for the differentiation and determination of the All-trans retinoic acid and can be 
considered an effective and alternative procedure for the analyses of this important class of 
natural compounds. 
 
 
